69 related articles for article (PubMed ID: 24147346)
1. Treatment with Cordyceps sinensis enriches Treg population in peripheral lymph nodes and delays type I diabetes development in NOD mice.
Wang MF; Zhu QH; He YG
Pharmazie; 2013 Sep; 68(9):768-71. PubMed ID: 24147346
[TBL] [Abstract][Full Text] [Related]
2. Upregulating CD4+CD25+FOXP3+ regulatory T cells in pancreatic lymph nodes in diabetic NOD mice by adjuvant immunotherapy.
Tian B; Hao J; Zhang Y; Tian L; Yi H; O'Brien TD; Sutherland DE; Hering BJ; Guo Z
Transplantation; 2009 Jan; 87(2):198-206. PubMed ID: 19155973
[TBL] [Abstract][Full Text] [Related]
3. Total coumarins from Urtica dentata Hand prevent murine autoimmune diabetes via suppression of the TLR4-signaling pathways.
Wang J; Lu J; Lan Y; Zhou H; Li W; Xiang M
J Ethnopharmacol; 2013 Mar; 146(1):379-92. PubMed ID: 23340441
[TBL] [Abstract][Full Text] [Related]
4. Immunoregulatory Cordyceps sinensis increases regulatory T cells to Th17 cell ratio and delays diabetes in NOD mice.
Shi B; Wang Z; Jin H; Chen YW; Wang Q; Qian Y
Int Immunopharmacol; 2009 May; 9(5):582-6. PubMed ID: 19557879
[TBL] [Abstract][Full Text] [Related]
5. Critical role of IFN-gamma in CFA-mediated protection of NOD mice from diabetes development.
Mori Y; Kodaka T; Kato T; Kanagawa EM; Kanagawa O
Int Immunol; 2009 Nov; 21(11):1291-9. PubMed ID: 19778991
[TBL] [Abstract][Full Text] [Related]
6. Immunoglobulin and cytokine production from mesenteric lymph node lymphocytes is regulated by extracts of Cordyceps sinensis in C57Bl/6N mice.
Park DK; Choi WS; Park PJ; Kim EK; Jeong YJ; Choi SY; Yamada K; Kim JD; Lim BO
J Med Food; 2008 Dec; 11(4):784-8. PubMed ID: 19053874
[TBL] [Abstract][Full Text] [Related]
7. All-trans retinoic acid inhibits type 1 diabetes by T regulatory (Treg)-dependent suppression of interferon-gamma-producing T-cells without affecting Th17 cells.
Van YH; Lee WH; Ortiz S; Lee MH; Qin HJ; Liu CP
Diabetes; 2009 Jan; 58(1):146-55. PubMed ID: 18984738
[TBL] [Abstract][Full Text] [Related]
8. Pancreas-infiltrating Th1 cells and diabetes develop in IL-12-deficient nonobese diabetic mice.
Trembleau S; Penna G; Gregori S; Chapman HD; Serreze DV; Magram J; Adorini L
J Immunol; 1999 Sep; 163(5):2960-8. PubMed ID: 10453045
[TBL] [Abstract][Full Text] [Related]
9. Ras inhibition attenuates pancreatic cell death and experimental type 1 diabetes: possible role of regulatory T cells.
Aizman E; Mor A; George J; Kloog Y
Eur J Pharmacol; 2010 Sep; 643(1):139-44. PubMed ID: 20599916
[TBL] [Abstract][Full Text] [Related]
10. Protection of IFN-gamma signaling-deficient NOD mice from diabetes by cyclophosphamide.
Mori Y; Kato T; Kodaka T; Kanagawa EM; Hori S; Kanagawa O
Int Immunol; 2008 Sep; 20(9):1231-7. PubMed ID: 18644830
[TBL] [Abstract][Full Text] [Related]
11. Dynamic changes of the Th17/Tc17 and regulatory T cell populations interfere in the experimental autoimmune diabetes pathogenesis.
Yaochite JN; Caliari-Oliveira C; Davanso MR; Carlos D; Malmegrim KC; Cardoso CR; Ramalho LN; Palma PV; da Silva JS; Cunha FQ; Covas DT; Voltarelli JC
Immunobiology; 2013 Mar; 218(3):338-52. PubMed ID: 22704522
[TBL] [Abstract][Full Text] [Related]
12. Different modulation of Ptpn22 in effector and regulatory T cells leads to attenuation of autoimmune diabetes in transgenic nonobese diabetic mice.
Yeh LT; Miaw SC; Lin MH; Chou FC; Shieh SJ; Chuang YP; Lin SH; Chang DM; Sytwu HK
J Immunol; 2013 Jul; 191(2):594-607. PubMed ID: 23752610
[TBL] [Abstract][Full Text] [Related]
13. NOD fetal thymus organ culture: an in vitro model for the development of T cells involved in IDDM.
Wilson SS; DeLuca D
J Autoimmun; 1997 Oct; 10(5):461-72. PubMed ID: 9376074
[TBL] [Abstract][Full Text] [Related]
14. Ras inhibition increases the frequency and function of regulatory T cells and attenuates type-1 diabetes in non-obese diabetic mice.
Mor A; Kloog Y; Keren G; George J
Eur J Pharmacol; 2009 Aug; 616(1-3):301-5. PubMed ID: 19527709
[TBL] [Abstract][Full Text] [Related]
15. IL-4 prevents insulitis and insulin-dependent diabetes mellitus in nonobese diabetic mice by potentiation of regulatory T helper-2 cell function.
Cameron MJ; Arreaza GA; Zucker P; Chensue SW; Strieter RM; Chakrabarti S; Delovitch TL
J Immunol; 1997 Nov; 159(10):4686-92. PubMed ID: 9366391
[TBL] [Abstract][Full Text] [Related]
16. Diabetogenic T cells are primed both in pancreatic and gut-associated lymph nodes in NOD mice.
Jaakkola I; Jalkanen S; Hänninen A
Eur J Immunol; 2003 Dec; 33(12):3255-64. PubMed ID: 14635033
[TBL] [Abstract][Full Text] [Related]
17. A new type of CD4+ suppressor T cell completely prevents spontaneous autoimmune diabetes and recurrent diabetes in syngeneic islet-transplanted NOD mice.
Han HS; Jun HS; Utsugi T; Yoon JW
J Autoimmun; 1996 Jun; 9(3):331-9. PubMed ID: 8816968
[TBL] [Abstract][Full Text] [Related]
18. B7-H4.Ig inhibits the development of type 1 diabetes by regulating Th17 cells in NOD mice.
Lee IF; Wang X; Hao J; Akhoundsadegh N; Chen L; Liu L; Langermann S; Ou D; Warnock GL
Cell Immunol; 2013 Mar; 282(1):1-8. PubMed ID: 23623902
[TBL] [Abstract][Full Text] [Related]
19. Effects of insulin like growth factor-1 and insulin on effector T cells generating autoimmune diabetes.
Bergerot I; Fabien N; Thivolet C
Diabetes Metab; 1996 Jul; 22(4):235-9. PubMed ID: 8767168
[TBL] [Abstract][Full Text] [Related]
20. Early events in islets and pancreatic lymph nodes in autoimmune diabetes.
Aspord C; Rome S; Thivolet C
J Autoimmun; 2004 Aug; 23(1):27-35. PubMed ID: 15236750
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]